跳至主要内容
临床试验/JPRN-UMIN000002291
JPRN-UMIN000002291已完成2 期

Efficacy and Safety of Zoledronic acid on urological cancer patients with bone metastasis: a phase II clinical study. - Efficacy and Safety of Zoledronic acid on urological cancer patients with bone metastasis: a phase II clinical study.

Department of Urology, Graduate School of Medical Sciences, Kyushu University0 个研究点目标入组 100 人开始时间: 2009年8月10日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1.Experience of bisphosphonate administration (orally or iv) 2.Experience of radiation therapy to bone lesion within 3 months. 3.Experience of 89Sr injection 4.Patients suffering from Renal failure 5.Secnod cancer except above target urological cancer 6.Planned invasive dental therapy and under invasive dental therapy 7.Femail during pregnancy or with possible pregnancy. Female during lactation 8.Coexsistence with mental disorder or neurological symptom 9.disqualified by a medical doctor

研究者

发起方
Department of Urology, Graduate School of Medical Sciences, Kyushu University

相似试验